Apple Inc. (AAPL)
Verdict history · AAPL
Every call Verdix has made on AAPL.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
See methodology for how verdicts are produced. Full track record →
Why the panel isn’t ready to call AAPL yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Information Technology · 2026-08-08 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitHIGH confidence
Why
Six investing frameworks, from deep-value to disruptive-innovation, unanimously agree Apple is an extraordinary business, but all six also agree the stock offers no margin of safety at 35x earnings. The debate is not whether to own Apple, but at what price, with specific technical and fundamental triggers identified for when the waiting ends.Level to watch
Key resistance 316.06+0.9% from 313.33
Next catalyst
Trigger to confirm the breakout: A weekly close above $317.40 with expanding volume clears the resistance cloud toward the all-time high of $344.57 and would signal the supply fears are overblown.The panel's take
Verdict: WAIT · Conviction: HIGH · Last price: 313.33
What changed since 2026-08-01:
- Price: 308.91 → 313.33 (+1.43%)
- Panel: 1 of 5 → 0 of 6 now Bullish — composition also changed: added The Disruptive-Innovation Seeker, The Scuttlebutt Growth Investor; removed The Macro Opportunist
- Trigger: BUY if: (1) weekly close above $317.40 with expanding volume, clearing the resistance cloud toward ATH $344.57, OR (2) pullback to $290-300 range (P/E ~28-30x) offering a real margin of safety. SELL if: weekly close below $299.89 (weekly EMA20) breaks the near-term uptrend structure, signaling the Stage 2 thesis is in jeopardy — or if the September-quarter earnings show margin compression below management's already-cautious guidance coupled with no strategic clarity from incoming CEO Ternus.
- Verdict: WAIT (unchanged)
The previous panel included one bullish voice (The Macro Opportunist) alongside four cautious ones, producing a medium-conviction WAIT. Swapping in The Scuttlebutt Growth Investor and The Disruptive-Innovation Seeker removed the lone bull and added two more price-conscious frameworks, both of which independently praised the business but arrived at 'wait for a better price.' With zero bullish voices across six frameworks and the stock still consolidating below resistance, the WAIT conviction stepped up to HIGH.
This is a textbook BUY vs WAIT split. The bulls (technical-scout, fundamental-scout) and the price-conscious voices (The Moat Compounder, The Scuttlebutt Growth Investor, The Disruptive-Innovation Seeker) all agree Apple is a world-class business, and their objection is purely entry price, not thesis deterioration. The two true bears (The Intrinsic-Value Modeler at negative 21% versus fair value, The GARP Operator on PEG discipline) are outnumbered by voices who would buy at a better price rather than avoid the stock entirely. WAIT wins over HOLD because the business itself is not in question, and there are specific, named entry triggers (a weekly close above $317, a pullback to $290 to 300, P/E compression to 28 to 30x).
Key levels
Key levels · AAPL
USD · as of 2026-08-08Analyst consensus target 313.33 USD · range 313.33–313.33
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Apple Inc. past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat⚫ NeutralMed
Signal: Apple's ecosystem switching costs make it perhaps the widest consumer technology moat I have ever seen, but at 35x trailing earnings and a PEG of 2.46, the margin of safety is nonexistent, and zero insider purchases against $112 million in sales tells me those closest to the business do not see a bargain either. Conviction: Multiple independent warnings converge on the same caution signal here: management's own 'hundred-year flood' language on memory costs, explicit supply-constraint guidance, insider selling without a single offsetting purchase, and a fragile technical structure.
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: A base-case fair value of $245 per share, 21% below the current price, with a terminal value weighting of roughly 75%, means the stock needs either sustained 10% revenue growth or a lower discount rate just to justify $312, and neither is defensible against the supply and leadership headwinds management itself is flagging. Conviction: Terminal assumptions carry real sensitivity here: a successful AI product cycle or faster-than-expected supply normalization could shift the narrative, but the complete absence of insider buying at these levels makes the bearish base case hard to dismiss regardless.
The Forensic SkepticContrarian/Forensic⚫ NeutralMed
Signal: Management is explicitly warning of supply scrambling and what it calls a 'hundred-year flood' in memory costs, yet zero insider purchases against $112 million in insider sales reveals a gap between what the market is pricing in and what those running the business are signaling with their own capital. Conviction: Insider behavior, management's own cautious language, and a PEG of 2.46 against a roughly 3% three-year revenue CAGR line up into a rare alignment of independent signals that the price assumes a perfection the fundamentals do not support.
The GARP OperatorGrowth (GARP)🔴 BearishMed
Signal: A PEG ratio of 2.46, more than double my ceiling for a Stalwart, means you are paying a steep premium for a company whose recent 16% revenue quarter is an exception to a roughly 3% CAGR trend, while management simultaneously warns of supply headwinds and heads for the exits. Conviction: A rare trifecta strengthens this: an overstretched PEG, explicit management cost warnings, and a CEO transition. Any one of these would give me pause; all three together make the bearish case unusually straightforward.
The Scuttlebutt Growth InvestorGrowth/Management⚫ NeutralMed
Signal: Apple scores 14 out of 15 on my quality checklist, an extraordinarily rare result, and management's candor about the supply crisis is exactly what I look for, but the incoming CEO was conspicuously quiet on his first earnings call, and at 35x earnings even the finest business demands patience. Conviction: Near-perfect checklist scores and genuine management transparency build high confidence in the long-term thesis, though the near-term entry stays capped by one unresolved variable: whether John Ternus has the strategic vision to sustain Apple's innovation engine.
The Disruptive-Innovation SeekerDisruptive Innovation⚫ NeutralLow
Signal: Apple Intelligence and Vision Pro could expand the addressable market to $1.2 trillion within five years, but at Apple's scale the $122 billion annual buyback, not disruptive innovation, is the real compounding engine, and an expected 4 to 5% CAGR is uninspiring for innovation-focused capital. Conviction: The embryonic stage of Apple's innovation platforms relative to its $3.5 trillion base constrains this, and the 12 to 18 months of margin pressure Cook himself forecast pushes any disruptive payoff well beyond the visible horizon.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six frameworks agree Apple is a world-class business: the ecosystem moat, brand loyalty, cash generation, and capital-return discipline are effectively undisputed.
- All six agree the current valuation (35x trailing earnings, a PEG of 2.46) offers no margin of safety; not one voice argues the stock is cheap or even fairly priced.
- All six flag the CEO transition from Tim Cook to John Ternus as a meaningful source of uncertainty that deserves a discount, not a premium.
- All six cite the absence of insider buying alongside significant insider selling ($112M over 90 days) as a cautionary signal that management sees more risk than opportunity.
- All six acknowledge that management's own explicit warnings, memory costs framed as a 'hundred-year flood,' supply scrambling, FX headwinds, are genuine operational headwinds, not routine conservatism.
The real debate
- The Scuttlebutt Growth Investor sees a 14 of 15 checklist score and argues existing holders should stay put, while The GARP Operator sees a PEG of 2.46 and flatly refuses to own the stock at any price above $290, a real tension between quality-conviction and price-discipline even among the cautious camp.
- The Moat Compounder treats the supply headwinds as temporary adversity that will eventually create a buying opportunity at a fair price, while The Intrinsic-Value Modeler sees them as evidence that the recent growth acceleration is cyclical rather than structural, implying the fair value is permanently lower.
- The Disruptive-Innovation Seeker sees on-device AI as a genuine TAM expander that could drive a replacement supercycle, while The Forensic Skeptic sees the same AI narrative as already fully priced into a 35x multiple, leaving zero edge for new buyers.
The question it comes down to: Will Apple's supply constraints and CEO transition prove to be temporary headwinds that create a buying opportunity once the price corrects, or are they early signals that the growth acceleration is cyclical and the current 35x multiple is structurally unsupportable?
The bottom line
- Trigger to confirm the breakout: A weekly close above $317.40 with expanding volume clears the resistance cloud toward the all-time high of $344.57 and would signal the supply fears are overblown.
- Buyable accumulation zone: A pullback to the $290 to 300 range compresses the P/E to roughly 28 to 30x, the level multiple panelists independently identified as offering a genuine margin of safety.
- Risk to monitor: A weekly close below $299.89 (the weekly EMA20) breaks the near-term uptrend structure and would put the entire Stage 2 thesis in jeopardy.
- Next catalyst: The September-quarter earnings report in late October 2026 will reveal whether memory cost pressures are peaking or accelerating, and marks incoming CEO John Ternus's first full quarter of commentary.
- Signal that reverses the insider skew: Any insider purchase, even a single open-market buy by a director or C-suite executive, would reverse one of the most universally cited bearish signals across all six frameworks.
contact@verdixhq.com · Published 2026-08-08 · Prices as of 2026-08-08 · Time horizon: 3–12 months · No direct position held in AAPL · AAPL verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated